research
acut
respiratori
infect
human
popul
limit
certain
methodolog
difficulti
first
acut
natur
make
time
diagnosi
difficult
second
symptom
usual
uniqu
specif
pathogen
difficulti
imped
collect
epidemiolog
eg
risk
factor
acut
respiratori
infect
clinic
eg
cours
sever
infect
data
well
biosampl
pathogen
identif
particular
realtim
collect
diagnost
specimen
nasal
nasopharyng
swab
acut
respiratori
infect
season
necessari
link
symptomat
data
specif
pathogen
therefor
urgent
need
develop
epidemiolog
research
tool
ensur
time
detect
incid
acut
respiratori
infect
collect
diagnost
biosampl
episod
epidemiolog
studi
acut
respiratori
infect
base
medic
set
conduct
specif
target
popul
train
medic
personnel
data
occurr
sever
symptom
collect
studi
either
retrospect
usual
end
acut
respiratori
infect
season
prospect
instanc
use
diarybas
questionnair
recent
modern
commun
tool
weekli
email
internetbas
questionnair
introduc
populationbas
studi
collect
realtim
data
respiratori
infect
recent
studi
influenza
infect
short
messag
servic
sm
use
addit
email
main
limit
studi
lack
pathogen
identif
specif
episod
acut
respiratori
infect
nasal
swab
pathogen
detect
usual
collect
studi
personnel
studi
site
hospit
howev
due
logist
problem
higher
cost
difficult
organ
populationbas
studi
inher
larger
sampl
size
sever
recent
studi
subject
ask
obtain
swab
nare
selfswab
detect
viral
respiratori
pathogen
studi
perform
u
r
object
examin
feasibl
combin
commun
email
selfcollect
nasal
swab
prospect
detect
acut
respiratori
infect
nonmed
set
method
studi
conduct
among
conveni
sampl
employe
n
research
institut
decemb
realtim
data
occurr
acut
respiratori
symptom
nasal
selfswab
collect
prospect
autom
weekli
email
remind
mechan
revers
transcript
polymeras
chain
reaction
rtpcr
use
detect
respiratori
viral
pathogen
swab
result
fiftyon
particip
complet
studi
studi
design
well
accept
thirti
particip
report
least
one
episod
acut
respiratori
infect
return
nasal
swab
studi
period
eight
particip
report
two
episod
major
difficulti
take
selfswab
prefer
swab
studi
personnel
particip
obtain
return
swab
within
recommend
time
viral
respiratori
pathogen
detect
swab
coronavirus
rhinovirus
b
constitut
posit
swab
conclus
combin
emailbas
symptomat
surveil
nasal
selfswab
promis
power
tool
realtim
identif
incid
case
acut
respiratori
infect
associ
pathogen
populationbas
studi
intern
societi
infecti
diseas
publish
elsevi
ltd
right
reserv
healthcar
environ
instanc
parent
collect
swab
symptomat
children
present
pediatr
medic
evalu
nurs
selfswab
symptomat
episod
studi
compar
two
measur
prevent
influenza
transmiss
uk
swab
collect
nasal
specimen
sent
individu
contact
health
advic
inform
servic
nh
direct
influenzalik
symptom
populationbas
studi
conduct
among
parent
collect
nasal
swab
children
home
thu
feasibl
nasal
selfswab
detect
respiratori
pathogen
populationbas
studi
adult
remain
demonstr
moreov
littl
known
whether
ad
benefit
result
activ
symptomat
surveil
conduct
ensur
time
selfcollect
swab
time
window
caus
pathogen
detect
therefor
examin
feasibl
combin
emailbas
activ
symptomat
surveil
nasal
selfswab
detect
viral
respiratori
pathogen
prospect
studi
span
one
acut
respiratori
infect
season
conduct
prospect
studi
among
employe
helmholtz
centr
infect
research
hzi
braunschweig
germani
decemb
aprilmay
decemb
invit
particip
studi
sent
employe
age
year
intern
email
system
invit
contain
link
institut
intranet
inform
studi
made
avail
subject
elig
studi
particip
vaccin
season
influenza
season
staff
depart
infect
genet
due
ethic
consider
plan
leav
braunschweig
studi
period
studi
approv
ethic
committe
state
board
physician
german
feder
state
lower
saxoni
fiftythre
particip
respond
invit
email
correspond
respons
rate
approxim
figur
subject
gave
written
inform
consent
enter
studi
baselin
decemb
inform
sociodemograph
sex
age
educ
profess
countri
birth
number
individu
live
household
etc
contact
anim
histori
vaccin
influenza
gener
health
statu
collect
selfadminist
questionnair
preseason
blood
sampl
also
obtain
time
aprilmay
studi
particip
reinvit
give
postseason
blood
sampl
fill
short
questionnair
everi
particip
complet
poststudi
questionnair
blood
sampl
receiv
remuner
serum
sampl
store
howev
conclus
studi
decid
forgo
origin
plan
influenza
hemagglutin
inhibit
assay
unexpectedli
low
incid
influenza
infect
germani
studi
period
januarymarch
particip
ask
take
swab
one
anterior
nare
return
studi
site
soon
possibl
least
one
follow
acut
respiratori
symptom
sudden
onset
stuffi
run
nose
cough
sore
throat
fever
receiv
instruct
physician
sk
perform
nasal
swab
briefli
swab
insert
one
nostril
depth
cm
rotat
three
time
place
transport
medium
two
kit
nasal
swab
contain
regular
flock
swab
mold
breakpoint
copan
brescia
itali
product
number
viral
univers
transport
medium
given
particip
symptomat
surveil
weekli
autom
email
messag
sent
particip
contain
remind
take
swab
onset
least
one
abovement
symptom
instruct
collect
store
return
swab
visual
instruct
collect
swab
also
avail
packag
particip
instruct
store
selfcollect
swab
refriger
return
soon
possibl
studi
team
upon
receipt
studi
site
swab
held
analysi
low
respons
rate
conduct
nonrespond
survey
april
figur
survey
done
selfadminist
questionnair
sent
via
intern
email
system
maintain
anonym
respond
individu
n
ask
return
complet
questionnair
inhous
mail
among
item
inform
collect
regard
reason
particip
studi
occurr
respiratori
infect
studi
period
data
describ
percentag
categor
variabl
median
rang
continu
variabl
differ
group
test
chisquar
test
categor
variabl
mannwhitney
utest
continu
variabl
overal
minor
differ
particip
nonrespond
tabl
particip
slightli
younger
nonrespond
p
approxim
particip
nonrespond
born
outsid
germani
p
half
subject
group
univers
degre
includ
univers
appli
scienc
slightli
higher
proport
smoker
among
respond
p
reason
particip
meet
inclus
criteria
time
absent
ill
vacat
read
invit
email
fear
blood
draw
concern
inadequ
data
protect
interest
inform
studi
unclear
subject
allow
give
one
reason
particip
provid
nasal
swab
symptomat
followup
period
eight
individu
two
symptomat
episod
thu
clinic
attack
rate
acut
respiratori
infect
base
least
one
report
symptom
tabl
particip
report
least
two
least
three
least
four
symptom
similar
proport
nonrespond
report
three
symptom
howev
proport
individu
report
mild
infect
one
two
symptom
significantli
lower
among
nonrespond
studi
particip
fiftyon
particip
complet
aspect
studi
one
particip
leav
studi
move
away
one
particip
lost
followup
nearli
studi
particip
found
studi
design
accept
tabl
vast
major
particip
would
particip
studi
six
percent
found
weekli
email
remind
take
swab
unaccept
major
collect
nasal
swab
report
difficulti
selfswab
one
particip
report
difficulti
open
swab
tube
felt
discomfort
perform
swab
particip
report
acut
respiratori
symptom
period
symptomat
surveil
n
selfcollect
nasal
swab
eight
subject
report
two
episod
respiratori
infect
eight
return
two
swab
end
studi
period
one
person
report
hesh
took
swab
bring
studi
center
reason
state
forgot
bring
swab
studi
center
particip
symptom
acut
respiratori
infect
collect
swab
within
first
day
onset
symptom
one
person
collect
swab
sixth
day
half
particip
brought
swab
studi
center
day
take
maximum
time
swab
collect
deliveri
week
respiratori
pathogen
virus
detect
revers
transcript
polymeras
chain
reaction
rtpcr
swab
tabl
frequent
record
one
human
coronavirus
swab
swab
coinfect
detect
two
specimen
influenza
virus
detect
differ
proport
posit
virus
neg
swab
term
particip
sex
age
level
educ
also
differ
time
elaps
onset
symptom
selfswab
figur
time
selfswab
arriv
swab
studi
center
figur
likewis
detect
effect
viral
detect
control
potenti
effect
variabl
time
chang
per
one
day
symptom
swab
adjust
odd
ratio
aor
confid
interv
ci
time
swab
deliveri
aor
ci
test
feasibl
combin
realtim
symptomat
surveil
nasal
selfswab
prospect
collect
epidemiolog
virolog
data
acut
respiratori
infect
preanalyt
phase
novel
approach
turn
highli
feasibl
accept
satisfact
complianc
timeli
logist
high
notabl
particip
selfswab
report
swab
easi
obtain
prefer
selfcollect
collect
studi
personnel
reason
high
degre
satisfact
may
selfswab
reduc
durat
frequenc
contact
studi
personnel
well
travel
studi
site
result
greater
conveni
would
like
impact
posit
complianc
largescal
prospect
studi
anoth
import
find
present
studi
neither
time
onset
symptom
selfswab
time
selfswab
specimen
arriv
laboratori
influenc
viral
detect
rate
agre
well
result
studi
uk
noteworthi
sinc
populationbas
studi
employ
selfswab
ship
time
need
includ
time
swab
collect
expect
arriv
specimen
studi
center
factor
time
could
address
studi
may
influenc
viral
detect
rate
one
obviou
candid
swab
techniqu
studi
physician
instruct
particip
standard
manner
proper
applic
techniqu
believ
inadequ
techniqu
impact
neg
rate
pathogen
detect
sinc
detect
rate
record
us
correspond
report
studi
employ
staffcollect
swab
similar
detect
technolog
also
two
recent
studi
show
differ
pathogen
detect
selfand
staffcollect
swab
anoth
factor
may
influenc
detect
rate
type
nasal
swab
use
specimen
collect
recent
smieja
et
al
develop
flock
nasal
midturbin
swab
compar
gold
standard
eg
rayon
nasal
nasopharyng
swab
midturbin
swab
turn
provid
better
result
base
epitheli
cell
count
gold
standard
use
regular
flock
swab
thu
use
midturbin
flock
swab
might
result
higher
detect
rate
studi
nonrespond
survey
allow
us
compar
prospect
particip
retrospect
nonrespond
collect
data
acut
respiratori
infect
symptom
reveal
prospect
approach
result
higher
rate
detect
mild
infect
thu
one
immedi
strength
use
activ
symptomat
surveil
populationbas
studi
acut
respiratori
infect
would
effici
identif
individu
reduc
suscept
infect
would
constitut
invalu
asset
largescal
studi
genet
determin
infect
suscept
resist
human
studi
use
selfswab
instead
swab
studi
personnel
detect
specif
pathogen
would
immens
attract
due
anticip
lower
cost
inde
expens
personnel
logist
estim
less
selfswab
use
instead
swab
studi
personnel
previou
method
activ
symptomat
surveil
exampl
weekli
telephon
call
daili
symptom
diari
howev
method
might
costli
lower
complianc
rate
limit
address
includ
repres
studi
popul
instanc
higherthanexpect
proport
femal
highli
educ
subject
moreov
due
work
research
institut
particip
could
expect
recept
studi
design
gener
popul
sinc
email
becom
primari
tool
commun
profession
work
environ
includ
institut
popul
sampl
present
studi
may
higher
accept
modern
commun
tool
gener
popul
studi
need
regard
use
electron
commun
method
populationbas
studi
particularli
target
less
educ
elderli
lastli
due
unexpect
near
absenc
influenza
infect
studi
period
could
evalu
use
studi
design
detect
influenza
infect
inde
consid
upper
respiratori
symptom
occur
fever
episod
influenza
infect
inclus
surveil
question
influenzaassoci
symptom
eg
myalgia
headach
would
like
increas
effici
screen
influenza
infect
emailbas
surveil
combin
emailbas
activ
symptomat
surveil
selfcollect
nasal
swab
ensur
prospect
accur
collect
data
incid
episod
acut
respiratori
infect
time
sampl
collect
detect
respiratori
pathogen
promis
effici
costeffect
approach
populationbas
studi
epidemiolog
respiratori
infect
